Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Exercise of Options and Director Dealing

6 Dec 2018 07:00

RNS Number : 5599J
Surface Transforms PLC
06 December 2018
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Surface Transforms plc

 

("Surface Transforms" or the "Company")

 

Exercise of Options and Director Dealing

 

Surface Transforms plc (AIM: SCE) announces that the Company was notified on 5 December 2018 that Dr Kevin Johnson (CEO of Surface Transforms Plc) exercised options over 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares").

 

Specifically, on 5 December 2018, Dr Kevin Johnson purchased 345,000 Ordinary Shares at a price of 9p per Ordinary Share and purchased 330,000 Ordinary Shares at a price of 11.5p.

 

Following the above transactions, Dr Johnson will be beneficially interested in 799,000 Ordinary Shares, which equates to approximately 0.6 per cent. of the Company's total issued share capital.

 

Dr Johnson has advised that he intends to transfer all of these shares to his SIPP but this will not change his beneficial interest in the Company.

 

Admission and Total Voting Rights

 

The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 675,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8.00 a.m. on 11 December 2018. Following Admission, the total number of voting rights in the Company will be 123,710,416 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

- Ends -

 

 

 

For enquiries, please contact:

Surface Transforms plc

 

 

Kevin Johnson, CEO

Michael Cunningham CFO

 

+44 151 356 2141

+44 151 348 8882

David Bundred, Chairman

+44 7785 388 848

 

Cantor Fitzgerald Europe (Nomad & Joint-Broker)

+44 20 7894 7000

David Foreman, Richard Salmond, Michael Boot (Corporate Finance)

Caspar Shand Kydd, Gregor Paterson (Sales)

 

 

 

FinnCap Ltd (Joint-Broker)

+44 20 7220 0500

Richard Chambers (Corporate Broking)

Ed Frisby / Giles Rolls (Corporate Finance)

 

 

 

For further Company details, visit www.surfacetransforms.com.

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

 

 

 

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMR") and persons closely associated with them ("PCA")

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Dr Kevin Johnson

2

Reason for notification

 

 

 

a.

Position/Status

PDMR

CEO

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Surface Transforms plc

b.

LEI

213800GQHNJPE5O8XO79

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 1p each 

ISIN: GB0002892528

b.

Nature of the transaction

Purchase of 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares).

 

c.

Price(s) and volume(s)

- Transaction 1 (Purchase)

 

- Transaction 2

(purchase)

 

Price(s)

Volume(s)

9.00p

345,000

11.5p

330,000

 

d.

Aggregated information

- Transaction 1

(purchase)

 

- Transaction 2

(purchase)

Price(s)

Aggregated volume(s)

Aggregated Total

9p

345,000

£31,050.00

11.5p

330,000

£37,950.00

 

e.

Date of the transaction

5/12/2018

f.

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGGPCPUPRGWA
Date   Source Headline
27th Feb 20187:00 amRNSHalf-year Report
4th Jan 20187:00 amRNSGrant of Options
2nd Jan 201812:05 pmRNSAppointment of new Financial Director
28th Nov 20172:18 pmRNSResult of AGM
20th Nov 20177:00 amRNSTrading and Operations Update
20th Sep 201712:07 pmRNSHolding(s) in Company
20th Sep 20179:34 amRNSGrant of Options
19th Sep 20177:00 amRNSPreliminary Results and Notice of AGM
9th Aug 20173:47 pmRNSResult of Open Offer Excess
27th Jul 20174:29 pmRNSHolding(s) in Company
26th Jul 201711:21 amRNSOpen Offer Excess
25th Jul 201711:51 amRNSResult of General Meeting
25th Jul 201711:13 amRNSResult of Open Offer
6th Jul 20173:00 pmRNSDirector/PDMR Shareholding
6th Jul 201712:09 pmRNSResult of Placing
6th Jul 201711:45 amRNSResult of Placing
6th Jul 20177:00 amRNSProposed Placing and Open Offer
20th Jun 20177:01 amRNSInvestors Open Day
20th Jun 20177:00 amRNSOperations, Customer and Pre Close Trading Update
18th Apr 20174:56 pmRNSExercise of Options
16th Mar 20178:20 amRNSExercise of Options
13th Feb 20177:00 amRNSHalf Yearly Results
2nd Feb 20177:00 amRNSTrading Update
6th Jan 20173:49 pmRNSChange of Registered Office
8th Dec 20167:00 amRNSTrading Update
29th Nov 20161:14 pmRNSResult of AGM
18th Oct 20164:14 pmRNSHolding(s) in Company
10th Oct 20167:00 amRNSPreliminary Results and Trading Statement
3rd Oct 20167:00 amRNSExercise of Options
5th Sep 20167:00 amRNSNotice of Results
2nd Aug 201610:42 amRNSHolding(s) in Company
11th Jul 20167:00 amRNSPre-Production Technology Development Agreement
15th Jun 20167:00 amRNSTrading, Premises and Operating Update
14th Apr 20165:18 pmRNSDirector Dealing
14th Apr 20162:33 pmRNSDirector Dealing & Director Interests in Company
14th Apr 20167:00 amRNSResult of Open Offer and Total Voting Rights
11th Apr 20167:00 amRNSDirector Dealing
6th Apr 201612:18 pmRNSHolding(s) in Company
4th Apr 20162:01 pmRNSResult of General Meeting
29th Mar 20167:00 amRNSDirector Dealing
18th Mar 20167:00 amRNSPlacing, Open Offer & Notice of General Meeting
18th Feb 20167:00 amRNSGrant Income of £600,000 and New Factory
3rd Feb 20167:00 amRNSHalf Yearly Results
7th Dec 20157:00 amRNSTrading Update
24th Nov 20154:00 pmRNSResult of AGM
12th Nov 201512:50 pmRNSReplacement: Exercise of Options
12th Nov 20157:00 amRNSExercise of Options
20th Oct 20158:51 amRNSHolding(s) in Company
8th Oct 201510:36 amRNSHolding(s) in Company
2nd Oct 201512:00 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.